BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 30642734)

  • 1. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2.
    Coropciuc RG; Grisar K; Aerden T; Schol M; Schoenaers J; Politis C
    Br J Oral Maxillofac Surg; 2017 Oct; 55(8):787-792. PubMed ID: 28760314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative non-surgical management in medication related osteonecrosis of the jaw: A retrospective study.
    Albanese M; Zotti F; Capocasale G; Bonetti S; Lonardi F; Nocini PF
    Clin Exp Dent Res; 2020 Oct; 6(5):512-518. PubMed ID: 32614524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
    Aljohani S; Gaudin R; Weiser J; Tröltzsch M; Ehrenfeld M; Kaeppler G; Smeets R; Otto S
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
    Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J
    J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB; O'Ryan F
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment?
    Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
    Oral Dis; 2018 Mar; 24(1-2):238-242. PubMed ID: 29480596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
    Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
    Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues with the surgical treatment of antiresorptive agent-related osteonecrosis of the jaws.
    Kagami H; Inoue M; Kobayashi A; Taguchi A; Li X; Yoshizawa M
    Oral Dis; 2018 Mar; 24(1-2):52-56. PubMed ID: 29480637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periosteal reaction of medication-related osteonecrosis of the jaw (MRONJ): clinical significance and changes during conservative therapy.
    Soutome S; Otsuru M; Hayashida S; Yanamoto S; Sasaki M; Takagi Y; Sumi M; Kojima Y; Sawada S; Iwai H; Umeda M; Saito T
    Support Care Cancer; 2021 Nov; 29(11):6361-6368. PubMed ID: 33884506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
    Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
    J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.
    Voss PJ; Steybe D; Poxleitner P; Schmelzeisen R; Munzenmayer C; Fuellgraf H; Stricker A; Semper-Hogg W
    Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G; Collangettes D; Dillies AF; Calvet L; Tournilhac O; Bay JO; Mahammedi H
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
    Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
    J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.